← The Wire
TECHNasdaq
BIO-TECHNE Corp
Biological Products, (No Diagnostic Substances) · MN · CIK 842023
Develops, manufactures, and sells life science reagents, instruments, and services for research, diagnostics, and bioprocessing markets
red 8-K · 90d🔥 High media attention
$8.45B
Market cap
$70.90
Last close
-0.1%
1D
+27.5%
5D
14.9M
Volume
Price · last 39 sessions+29.5%
May 4L $43.30 · H $71.00Jun 29
287
Total filings
Jun 26, 2026
Last filing
06/30
Fiscal year end
8-KExecutive Change · Material AgreementJun 26, 2026DEFA14ASOLICITING MATERIALJun 25, 20268-KReg FD DisclosureJun 25, 202610-Q10-QMay 6, 20268-KResults of Operations · Company UpdateMay 6, 20268-KExecutive Change · Company UpdateFeb 11, 202610-Q10-QFeb 4, 20268-KResults of Operations · Company UpdateFeb 4, 202610-Q10-QNov 5, 20258-KResults of Operations · Shareholder VoteNov 5, 2025DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSSep 19, 2025DEF 14ADEFINITIVE PROXY STATEMENTSep 19, 202510-K10-KAug 22, 20258-KResults of Operations · Company UpdateAug 6, 202510-Q10-QMay 8, 20258-KResults of Operations · Company UpdateMay 7, 20258-KReg FD DisclosureMay 6, 20258-KExecutive ChangeMar 4, 202510-Q10-QFeb 6, 20258-KExecutive Change · Results of OperationsFeb 5, 2025SC 13GSC 13GNov 14, 20248-KExecutive ChangeNov 5, 202410-Q10-QNov 5, 20248-KResults of Operations · Shareholder VoteOct 30, 2024DEFA14ABIO-TECHNE CORP - DEFA14ASep 12, 2024DEF 14ABIO-TECHNE CORP - DEF 14ASep 12, 202410-K10-KAug 22, 20248-KResults of Operations · Company UpdateAug 7, 202410-Q10-QMay 6, 20248-KResults of Operations · Company UpdateMay 1, 20248-KExecutive Change · Company UpdateApr 30, 202410-Q10-QFeb 7, 20248-KResults of Operations · Company UpdateFeb 1, 20248-KExecutive Change · Company UpdateJan 8, 202410-Q10-QNov 7, 20238-KResults of Operations · Shareholder VoteOct 31, 20238-KExecutive Change · Company UpdateOct 19, 2023DEFA14ABIO-TECHNE CORP - DEFA14ASep 13, 2023DEF 14ABIO-TECHNE CORP - DEF 14ASep 13, 202310-K10-KAug 23, 20238-KResults of Operations · Company UpdateAug 8, 202310-Q10-QMay 8, 20238-KResults of Operations · Company UpdateMay 3, 20238-KCompany UpdateApr 3, 20238-KCompany UpdateMar 1, 202310-Q10-QFeb 7, 20238-KResults of Operations · Company UpdateFeb 2, 20238-KExecutive Change · Company UpdateJan 31, 2023SC 13GSC 13GJan 20, 202310-Q10-QNov 7, 20228-KResults of Operations · Bylaw AmendmentNov 1, 2022DEFA14ABIO-TECHNE CORP - DEFA14ASep 14, 2022DEF 14ABIO-TECHNE CORP - DEF 14ASep 14, 20228-KMaterial AgreementSep 7, 202210-K10-KAug 24, 20228-KExecutive ChangeAug 5, 20228-KResults of Operations · Company UpdateAug 4, 202210-Q10-QMay 9, 20228-KResults of Operations · Company UpdateMay 4, 20228-KBylaw AmendmentApr 27, 202210-QFORM 10-QFeb 7, 20228-KResults of Operations · Company UpdateFeb 1, 20228-KExecutive Change · Company UpdateDec 22, 202110-QFORM 10-QNov 8, 20218-KResults of Operations · Company UpdateNov 2, 20218-KShareholder VoteOct 29, 2021DEFA14AFORM DEFA14ASep 15, 2021DEF 14ADEF 14ASep 14, 202110-KFORM 10-KAug 25, 20218-KResults of Operations · Company UpdateAug 5, 202110-QFORM 10-QMay 7, 20218-KResults of Operations · Company UpdateMay 6, 202110-QFORM 10-QFeb 8, 20218-KResults of Operations · Company UpdateFeb 2, 202110-QFORM 10-QNov 9, 20208-KResults of Operations · Company UpdateNov 5, 20208-KExecutive Change · Shareholder VoteNov 3, 2020DEFA14AFORM DEFA14ASep 15, 2020DEF 14AFORM DEF 14ASep 15, 202010-KFORM 10-KAug 26, 2020
Insider Activity
In the 90 days to Feb 17, 2026: 1 sold $117K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Herr Amy E.Director | Sell | 1,976 | $59.11 | $117K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 18 reputable articles.
MorningstarBio-Techne: Merck KGaA Agrees to Acquire Bio-Techne4d agoMorningstarBio-Techne to Be Acquired by Merck KGaA4d agoInvestor's Business DailyGermany's Merck KGaA Swoops In With $11.3 Billion Medtech Buyout4d agoMarketWatchBio-Techne Corp. stock outperforms competitors on strong trading day4d agoBarron'sBio-Techne Is Today’s Top S&P 500 Stock. Germany’s Merck to Buy Company for $11.3 Billion.4d agoWSJGermany’s Merck to Boost Lab-Tools Business With $11 Billion Bio-Techne Deal4d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance